Skip to content

Retrospective study of cases of people infected by Monkeypox in Rio de Janeiro

Retrospective study of cases of human infection by Monkeypox in the Rio de Janeiro city

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-2fdfwf5
Enrollment
Unknown
Registered
2023-02-16
Start date
2022-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monkeypox virus

Interventions

For this retrospective cohort project, all cases of monkeypox notified and followed up by the Epidemiological Surveillance of the municipality of Rio de Janeiro from March 2022 to February 2024 will b
V03.175.500
E05.318.308.980

Sponsors

Secretaria Municipal de Saúde do Rio de Janeiro
Lead Sponsor
Secretaria Municipal de Saúde do Rio de Janeiro
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Be assisted in health units in the city of Rio de Janeiro; have clinical and epidemiological data collected in notification and investigation forms for hMPX by the Municipal Epidemiological Surveillance

Exclusion criteria

Exclusion criteria: Absence of demographic information in the notification form; divergence of information between the laboratory diagnosis and the closure of the case;

Design outcomes

Primary

MeasureTime frame
Evaluate the demographic, behavioral and epidemiological characteristics of suspected cases of monkeypox, clinical manifestations, indications for hospitalization, proportion of cases involving professionals and proportion of incident cases among contacts of confirmed cases using secondary data referring to notifications and investigations of suspected cases of monkeypox between March 2022 and February 2024 in the municipality of Rio de Janeiro.

Secondary

MeasureTime frame
No secondary outcomes are expected.

Countries

Brazil

Contacts

Public ContactJosé Neto

Instituto Nacional de Infectologia - INI / Fiocruz

cerbino@fiocruz.br+55(21)38659695

Outcome results

None listed

Source: REBEC (via WHO ICTRP)